Key Record Dates
ClinicalTrials.gov Identifier: | NCT03275103 |
---|---|
Brief Title: | Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) |
First Submitted : | September 5, 2017 |
First Submitted that Met QC Criteria : | September 5, 2017 |
First Posted : | September 7, 2017 |
Last Update Submitted that Met QC Criteria : | May 18, 2023 |
Last Update Posted : | May 19, 2023 |